应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01672 歌礼制药-B
未开盘 06-17 16:08:37
9.910
+0.410
+4.32%
最高
10.040
最低
9.510
成交量
133.94万
今开
9.540
昨收
9.500
日振幅
5.58%
总市值
105.15亿
流通市值
105.15亿
总股本
10.61亿
成交额
1,317万
换手率
0.13%
流通股本
10.61亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
歌礼制药-B 6月17日回购200,000股,耗资约197.09万港元
公告速递 · 06-17 19:26
歌礼制药-B 6月17日回购200,000股,耗资约197.09万港元
歌礼制药-B(01672)6月17日斥资197.09万港元回购20万股
智通财经 · 06-17 19:23
歌礼制药-B(01672)6月17日斥资197.09万港元回购20万股
歌礼制药-B(01672)6月16日斥资186.26万港元回购20万股
智通财经 · 06-16 18:47
歌礼制药-B(01672)6月16日斥资186.26万港元回购20万股
歌礼制药-B:6月16日回购20万股,耗资约186.26万港元
公告速递 · 06-16 18:46
歌礼制药-B:6月16日回购20万股,耗资约186.26万港元
歌礼制药-B6月15日回购20万股,耗资约191.83万港元
公告速递 · 06-15 17:41
歌礼制药-B6月15日回购20万股,耗资约191.83万港元
歌礼制药-B(01672)6月15日斥资191.83万港元回购20万股
智通财经 · 06-15 17:40
歌礼制药-B(01672)6月15日斥资191.83万港元回购20万股
歌礼制药-B6月12日回购20万股,总额约201.18万港元
公告速递 · 06-12
歌礼制药-B6月12日回购20万股,总额约201.18万港元
歌礼制药-B于6月11日回购200,000股股份,耗资约196.69万港元
公告速递 · 06-11
歌礼制药-B于6月11日回购200,000股股份,耗资约196.69万港元
歌礼制药-B(01672)6月11日斥资196.69万港元回购20万股
智通财经 · 06-11
歌礼制药-B(01672)6月11日斥资196.69万港元回购20万股
歌礼制药-B于6月10日回购20万股,涉资约199.96万港元
公告速递 · 06-10
歌礼制药-B于6月10日回购20万股,涉资约199.96万港元
歌礼制药-B(01672)6月10日斥资199.96万港元回购20万股
智通财经 · 06-10
歌礼制药-B(01672)6月10日斥资199.96万港元回购20万股
歌礼制药-B:6月9日回购20万股股份,耗资约201.40万港元
公告速递 · 06-09
歌礼制药-B:6月9日回购20万股股份,耗资约201.40万港元
歌礼制药-B:6月8日回购20万股,涉资约200.80万港元
公告速递 · 06-08
歌礼制药-B:6月8日回购20万股,涉资约200.80万港元
歌礼制药-B(01672)6月8日斥资200.8万港元回购20万股
智通财经 · 06-08
歌礼制药-B(01672)6月8日斥资200.8万港元回购20万股
歌礼制药-B拟回购最多10%股份
公告速递 · 06-05
歌礼制药-B拟回购最多10%股份
歌礼制药-B:6月4日回购20万股,耗资约202.62万港元
公告速递 · 06-04
歌礼制药-B:6月4日回购20万股,耗资约202.62万港元
歌礼制药-B(01672)6月4日耗资约202.62万港元回购20万股
智通财经 · 06-04
歌礼制药-B(01672)6月4日耗资约202.62万港元回购20万股
歌礼制药-B:6月3日回购20万股,耗资约201.31万港元
公告速递 · 06-03
歌礼制药-B:6月3日回购20万股,耗资约201.31万港元
歌礼制药-B6月2日回购20万股股份,总涉资约205.65万港元
公告速递 · 06-02
歌礼制药-B6月2日回购20万股股份,总涉资约205.65万港元
歌礼制药-B(01672)6月2日耗资205.652万港元回购20万股
智通财经 · 06-02
歌礼制药-B(01672)6月2日耗资205.652万港元回购20万股
暂无数据
公司概况
公司名称:
歌礼制药-B
所属市场:
SEHK
上市日期:
--
主营业务:
歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎(NASH)或原发性胆汁性胆管炎(PBC)及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒(RSV)的ASC10、用于人类免疫缺陷病毒(HIV)功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。该公司在国内和国外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":9.91,"timestamp":1781683717004,"preClose":9.5,"halted":0,"volume":1339350,"delay":0,"changeRate":0.04315789473684212,"floatShares":1061000000,"shares":1061000000,"eps":-0.42860888234187927,"marketStatus":"未开盘","change":0.41,"latestTime":"06-17 16:08:37","open":9.54,"high":10.04,"low":9.51,"amount":13167273,"amplitude":0.055789,"askPrice":9.94,"askSize":10000,"bidPrice":9.91,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.4342835203410017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781746200000},"marketStatusCode":0,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":9.5,"openAndCloseTimeList":[[1781659800000,1781668800000],[1781672400000,1781683200000]],"volumeRatio":0.660635,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672/tweets","defaultTab":"tweets","newsList":[{"id":"1169275180","title":"歌礼制药-B 6月17日回购200,000股,耗资约197.09万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169275180","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169275180?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:26","pubTimestamp":1781695586,"startTime":"0","endTime":"0","summary":"歌礼制药-B于2026年6月17日发布翌日披露报表并公告最新股份购回情况。根据公告,公司于当日于香港联交所场内回购200,000股普通股,约占当日公司已发行股本0.0188%。回购价格最高每股10.02港元、最低每股9.6港元,合计支付约197.09万港元。公告显示,公司已获得的回购授权通过日期为2025年5月22日,授权范围内可回购股份总数为96,284,628股。本次回购完成后,公司于2026年6月17日的已发行股份仍为1,061,370,845股,库藏股数量为7,084,210股,合计1,068,455,055股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B 6月17日回购200,000股,耗资约197.09万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644743347","title":"歌礼制药-B(01672)6月17日斥资197.09万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644743347","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644743347?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:23","pubTimestamp":1781695410,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,于2026年6月17日斥资197.09万港元回购20万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1191","BK1161","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643593237","title":"歌礼制药-B(01672)6月16日斥资186.26万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643593237","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643593237?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:47","pubTimestamp":1781606872,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,该公司于2026年6月16日斥资186.26万港元回购20万股股份,每股回购价格为9.14-9.45港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1574","BK1515","01672","BK1161","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164547630","title":"歌礼制药-B:6月16日回购20万股,耗资约186.26万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164547630","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164547630?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:46","pubTimestamp":1781606760,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2026年6月16日发布公告称,公司当日在香港联交所场内回购普通股20万股,占其已发行股本约0.0188%。本次回购价格介乎每股9.14港元至9.45港元,合计耗资约186.26万港元。本次回购股份尚未注销,截至2026年6月16日,公司已发行股份总数仍为1,061,370,845股,库藏股数量为7,084,210股,总股本为1,068,455,055股。本次回购完成后,公司剩余可回购股数为87,798,628股。公司确认已按照香港联交所证券上市规则及相关法例要求进行本次股份购回。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B:6月16日回购20万股,耗资约186.26万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172085914","title":"歌礼制药-B6月15日回购20万股,耗资约191.83万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172085914","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172085914?lang=zh_cn&edition=full","pubTime":"2026-06-15 17:41","pubTimestamp":1781516479,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2026年6月15日发布翌日披露报表,公告当日于香港联交所回购普通股200,000股,占此前已发行股本约0.0188%。本次回购价格介乎每股9.30港元至10.10港元,合计耗资约191.83万港元。本次回购完成后,公司已发行股本保持1,061,370,845股,库藏股数量为7,084,210股,总股本为1,068,455,055股。回购授权于2025年5月22日通过,授权可回购股份总数为96,284,628股,迄今累计已回购8,286,000股,占授权通过当日已发行股本约0.8599%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B6月15日回购20万股,耗资约191.83万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643274825","title":"歌礼制药-B(01672)6月15日斥资191.83万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643274825","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643274825?lang=zh_cn&edition=full","pubTime":"2026-06-15 17:40","pubTimestamp":1781516414,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,于2026年6月15日,该公司斥资191.83万港元回购20万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01672","BK1574","01477","BK1191","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122549517","title":"歌礼制药-B6月12日回购20万股,总额约201.18万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122549517","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122549517?lang=zh_cn&edition=full","pubTime":"2026-06-12 18:32","pubTimestamp":1781260364,"startTime":"0","endTime":"0","summary":"歌礼制药-B于2026年6月12日发布公告,称当日于香港联交所场内回购200,000股普通股,约占公司已发行股本的0.0188%。本次回购每股价格介乎9.93港元至10.19港元,总涉资约2,011,760港元。此外,回购授权于2025年5月22日获股东大会通过,授权总数为96,284,628股,公司已累计在香港联交所及其他交易所购回8,086,000股,占授权通过当日已发行股份数目的0.8391%。公司在公告中确认,本次回购已遵守香港联交所上市规则及相关法律法规,并由公司秘书钟明辉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B6月12日回购20万股,总额约201.18万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107071582","title":"歌礼制药-B于6月11日回购200,000股股份,耗资约196.69万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107071582","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107071582?lang=zh_cn&edition=full","pubTime":"2026-06-11 18:32","pubTimestamp":1781173972,"startTime":"0","endTime":"0","summary":"歌礼制药-B于2026年6月11日发布公告,披露其在香港联交所场内进行了股份回购等事项。截至当日,公司已发行股份总数为1,061,370,845股,库藏股数为7,084,210股,合计1,068,455,055股。据公告,购回授权的决议于2025年5月22日通过,授权总规模为96,284,628股。截至目前,公司已在香港联交所及其他证券交易所合计回购7,886,000股,占购回授权通过当日已发行股本的0.8184%。公司确认本次回购行为符合香港联交所证券上市规则及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"歌礼制药-B于6月11日回购200,000股股份,耗资约196.69万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642228549","title":"歌礼制药-B(01672)6月11日斥资196.69万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642228549","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642228549?lang=zh_cn&edition=full","pubTime":"2026-06-11 18:30","pubTimestamp":1781173810,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,该公司于2026年6月11日斥资196.69万港元回购20万股股份,每股回购价格为9.63-10.11港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453231.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1161","01477","BK1515","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114959740","title":"歌礼制药-B于6月10日回购20万股,涉资约199.96万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114959740","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114959740?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:32","pubTimestamp":1781087552,"startTime":"0","endTime":"0","summary":"歌礼制药-B于2026年6月10日公告,显示当日回购普通股合计200,000股,约占公司已发行股本的0.0188%。本次回购每股价格介乎每股9.75港元至10.15港元,总金额为1,999,590港元。公司披露,截至2026年6月10日,其已发行股本为1,061,370,845股,库藏股为7,084,210股,合计1,068,455,055股。该批回购股份尚未完成注销,故目前公司已发行股本及库藏股数维持不变。公告并确认,本次回购已遵照香港联合交易所有限公司证券上市规则及相关法律法规的规定办理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B于6月10日回购20万股,涉资约199.96万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642440659","title":"歌礼制药-B(01672)6月10日斥资199.96万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642440659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642440659?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:28","pubTimestamp":1781087318,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,该公司于2026年6月10日斥资199.96万港元回购20万股股份,每股回购价格为9.75-10.15港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","01477","BK1191","BK1161","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113268805","title":"歌礼制药-B:6月9日回购20万股股份,耗资约201.40万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113268805","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113268805?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:16","pubTimestamp":1781000199,"startTime":"0","endTime":"0","summary":"歌礼制药-B 于2026年6月9日公告,公司当天在香港联交所场内回购普通股20万股,占已发行股本约0.0188%。回购价格介乎每股9.80港元至10.28港元,合计支付约2,013,990港元。回购授权的决议于2025年5月22日获通过,可回购股份总数为96,284,628股,目前已回购7,486,000股,剩余可回购股份为88,798,628股。公司确认本次回购符合香港联合交易所有限公司证券上市规则及当地适用法规的相关要求。本次公告由公司秘书鍾明輝签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B:6月9日回购20万股股份,耗资约201.40万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115806178","title":"歌礼制药-B:6月8日回购20万股,涉资约200.80万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115806178","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115806178?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:56","pubTimestamp":1780916192,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672)于2026年6月8日公告,公司当日于香港联交所场内回购20万股普通股,占已发行股本约0.0188%。本次回购每股价格介乎9.88港元至10.26港元,总金额约200.80万港元。\n回购完成后,公司已发行股本维持在1,061,370,845股,库藏股数为7,084,210股。本次回购基于2025年5月22日通过的购回授权,该授权允许公司回购共计96,284,628股。截至目前,公司已累计回购7,286,000股,占授权通过当日已发行股本约0.7561%。\n公司确认已遵守香港联交所上市规则及相关法律规定。公告由公司秘书钟明辉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B:6月8日回购20万股,涉资约200.80万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641048632","title":"歌礼制药-B(01672)6月8日斥资200.8万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641048632","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641048632?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:54","pubTimestamp":1780916097,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)发布公告,于2026年6月8日,该公司斥资200.8万港元回购20万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451526.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","BK1161","BK1515","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150875195","title":"歌礼制药-B拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1150875195","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150875195?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:10","pubTimestamp":1780650613,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司在公告中表示,公司董事会拟于2026年6月29日举行的股东周年大会上寻求一般性授权,可于授权获准当日已发行股份总数的10%范围内回购股份。董事会认为回购计划符合公司及股东的最佳利益。董事会表示,在获得上述回购授权后,将密切关注市场情况,有序开展购回安排,并在适用法例和监管要求范围内执行。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1133045149","title":"歌礼制药-B:6月4日回购20万股,耗资约202.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133045149","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133045149?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:31","pubTimestamp":1780572711,"startTime":"0","endTime":"0","summary":"2026年6月4日,歌礼制药有限公司发布翌日报表,披露最新股份回购情况。公告显示,公司于2026年6月4日于香港联交所场内回购股份200,000股,约占已发行股本的0.0188%。回购价格介乎每股9.8港元至10.31港元,合计付出约202.62万港元。本次回购后,公司已发行股本仍为1,061,370,845股,库藏股数量维持在7,084,210股。截至目前,已在交易所累计回购6,886,000股,占授权通过当日已发行股本约0.7146%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B:6月4日回购20万股,耗资约202.62万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640542861","title":"歌礼制药-B(01672)6月4日耗资约202.62万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640542861","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640542861?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:28","pubTimestamp":1780572500,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)公布,2026年6月4日耗资约202.62万港元回购20万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1515","BK1574","BK1191","01672","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145435342","title":"歌礼制药-B:6月3日回购20万股,耗资约201.31万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145435342","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145435342?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:31","pubTimestamp":1780479112,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2026年6月3日公告,当日通过香港联交所场内回购普通股20万股,约占公司已发行股本的0.0188%。回购价格区间为每股9.82港元至10.25港元,合计耗资约201.31万港元。根据2025年5月22日通过的回购授权,公司可回购股份总数为96,284,628股,截至目前已累计回购6,686,000股,占授权通过当日公司已发行股本约0.6938%。公司确认本次回购符合香港联交所上市规则和相关法规要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B:6月3日回购20万股,耗资约201.31万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177060361","title":"歌礼制药-B6月2日回购20万股股份,总涉资约205.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177060361","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177060361?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:16","pubTimestamp":1780395366,"startTime":"0","endTime":"0","summary":"2026年6月2日,歌礼制药有限公司公告称,当日于香港联交所回购普通股200,000股,约占已发行股本的0.0188%。本次回购每股价格介乎每股9.98港元至10.54港元,总涉资约205.65万港元。公司指出,此次回购基于其于2025年5月22日获得通过的购回授权,授权回购股份总数为9,628.46万股,目前已根据该授权累计回购6,486,000股,占授权通过当日已发行股本的0.6731%。公司同时确认已遵守香港联交所主板上市规则及相关法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B6月2日回购20万股股份,总涉资约205.65万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914694","title":"歌礼制药-B(01672)6月2日耗资205.652万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914694","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640914694?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:15","pubTimestamp":1780395335,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B(01672)公布,2026年6月2日耗资205.652万港元回购20万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1515","01672","BK1574","BK1191","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":-0.3791},{"period":"3month","weight":-0.3189},{"period":"6month","weight":-0.2377},{"period":"1year","weight":0.0795},{"period":"ytd","weight":-0.1299}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0531},{"period":"3month","weight":-0.0466},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0138},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎(NASH)或原发性胆汁性胆管炎(PBC)及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒(RSV)的ASC10、用于人类免疫缺陷病毒(HIV)功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.146882},{"month":2,"riseRate":0.75,"avgChangeRate":0.100059},{"month":3,"riseRate":0.375,"avgChangeRate":-0.044472},{"month":4,"riseRate":0.375,"avgChangeRate":-0.053142},{"month":5,"riseRate":0.375,"avgChangeRate":-0.01034},{"month":6,"riseRate":0.375,"avgChangeRate":-0.059385},{"month":7,"riseRate":0.571429,"avgChangeRate":0.032162},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.037953},{"month":9,"riseRate":0.125,"avgChangeRate":-0.072967},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023171},{"month":11,"riseRate":0.875,"avgChangeRate":0.185422},{"month":12,"riseRate":0.5,"avgChangeRate":0.087327}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}